Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Rick Admiraal

Clinical research fellow pediatric oncology
-
  • High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant

    • jan. 2024
    • Rick, Admiraal, et al
    • Cytotherapy
  • Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation

    • okt. 2023
    • Yu-Hsiang, Chiu, et al
    • Journal of scleroderma and related disorders
  • Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists

    • jul. 2023
    • , et al
    • Bone Marrow Transplantation
  • Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation

    • aug. 2022
    • Parastoo B, Dahi, et al
    • Transplantation and Cellular Therapy
  • Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

    • apr. 2022
    • Linde, Dekker, et al
    • Blood advances
View all publications